Fortress Biotech (FBIO) CFO Jin David Receives Award 2,967 Shares

What Happened Jin David, Chief Financial Officer of Fortress Biotech (FBIO), acquired 2,967 shares on 2026-04-01 under the issuer's Employee Stock Purchase Plan at $2.18 per share, for a total value of $6,456. The transaction is reported as an acquisition (transaction code A).

Key Details

• Transaction date and price: 2026-04-01 — 2,967 shares @ $2.18 each (total $6,456).
• Transaction type: Grant/award or other acquisition under the Employee Stock Purchase Plan (ESPP); reported as code A.
• Footnotes: F1 — acquisition reported voluntarily and treated as exempt under Rule 16b-3(d) and Rule 16b-3(c). F2 — total holdings noted in the filing include 1,230,000 shares underlying deferred restricted stock units.
• Filing timeliness: Reported and filed on 2026-04-01 (no late filing indicated).

Context Acquisitions under an employee stock purchase plan are routine compensation-related purchases and can reflect ongoing participation in company equity programs rather than a discrete market-timing signal. The dollar amount here ($6.5K) is modest relative to executive stakes; retail investors should view this as a routine ESPP purchase rather than a strong directional bet.